Podcasts about aventis

Nghe trọn sách nói Súng, Vi Trùng Và Thép trên ứng dụng Fonos: https://fonos.link/podcast-tvsn --Về Fonos:Fonos là Ứng dụng âm thanh số - Với hơn 13.000 nội dung gồm Sách nói có bản quyền, PodCourse, Podcast, Ebook, Tóm tắt sách, Thiền định, Truyện ngủ, Nhạc chủ đề, Truyện thiếu nhi. Bạn có thể nghe miễn phí chương 1 của tất cả sách nói trên Fonos. Tải app để trải nghiệm ngay!--Súng, Vi Trùng Và Thép: Định Mệnh Của Các Xã Hội Loài Người là cuốn sách nổi tiếng nhất của Jared Diamond, được xuất bản lần đầu vào năm 1997. Nội dung sách giải thích vì sao các nền văn minh Á – Âu (bao gồm cả Bắc Phi) lại tồn tại được, cũng như đã chinh phục các nền văn minh khác. Đồng thời, ông bác bỏ các lý thuyết về sự thống trị của các nền văn minh Á – Âu dựa trên trí tuệ, đạo đức hay ưu thế di truyền. Jared Diamond lập luận rằng, sự khác biệt về quyền lực và công nghệ giữa các xã hội loài người có nguồn gốc từ sự khác biệt về môi trường, trong đó sự khác biệt này được khuếch đại không ngừng. Qua đó, ông giải thích tại sao Tây Âu, chứ không phải các nền văn minh khác trong thế giới Á – Âu như Trung Quốc, lại trở thành các thế lực thống trị.Ngay sau khi ra mắt, cuốn sách đã trở thành cuốn sách bán chạy nhất trên thế giới, được dịch ra 33 thứ tiếng và nhận nhiều giải thưởng, trong đó có một giải Pulitzer, một giải thưởng Sách Khoa học Aventis và giải thưởng Khoa học Phi Beta Kap-pa năm 1997. Một bộ phim tài liệu truyền hình nhiều tập dựa trên cuốn sách đã được Hiệp hội Địa lý Quốc gia sản xuất vào năm 2005.Đến nay, sách đã bán được hàng triệu bản và vẫn được xem là một công trình nền tảng về địa lý liên ngành, toàn diện và đột phá.--Tìm hiểu thêm về Fonos: https://fonos.vn/Theo dõi Facebook Fonos: https://www.facebook.com/fonosvietnam/

David Miller kicks off the conversation with a summary of his life since Harvard. He went to Brown University, Providence, and then moved back to Boston, where he spent five years in Cambridge, Somerville, Arlington, and then moved to Santa Monica, California, where his wife was pursuing her fellowship. He then returned to Boston, where he has been for 20 years, minus a three-month stint in Paris, France. Technology Inventor,  Independent Contributor, and Instructor David met his wife, Ruth Herzman Miller, in October of his freshman year at Harvard. They have three daughters, and David has spent some time as a full-time dad with each of them. He majored in mathematics at Harvard and pure mathematics at graduate school at Brown. After a pause, he worked in speech and language processing at Bolt, Beranek and Newman (BBN) Technologies in Cambridge where he worked on developing speech to text transcription and information retrieval. He went to UCLA to learn bioinformatics and worked at a bioinformatics laboratory at the Molecular Biology Institute. In 2001, he returned to Boston and worked at Aventis Pharmaceuticals, now Sanofi Aventis, applying his knowledge in lead generation informatics. He stayed at Aventis for a few years before taking some time off the workforce. In 2008, David joined Google for 16 years, primarily on the search engine. He has worked on various projects, including the Google Books project and AI Overviews. He has also spent time at Google Paris, Zurich, and Tokyo. He has also taught computer science in the context of the Girls Who Code Project, where he distributed curriculum material to numerous chapters and hosted meetups. He also worked with Microsoft TEALS (technology and learning in schools), teaching ninth and 10th grade computer science. Inspired by French Theater  During the pandemic, revisited an interest he had discovered in Paris, French theater. He started studying French and learned about the annual Theater Festival in Avignon, France, which is the second largest Fringe Festival in the world. After visiting the festival in 2022, he decided to create a similar event in Boston. He started a limited liability corporation with knowledge of French, Boston theater scene, organizational capacity, and spare finance. The first production was performed in April 2024, and the second is set to open in November 2024. They are currently booking venues and signing contracts for their 2025-2026 season.  Google, AI, and The BERT Revolution The conversation turns to  AI, BERT, and Google. He explains that the feature of BERT was built to transform language problems into arithmetic problems, using embeddings in high-dimensional vector spaces to catch semantics. This allowed for more complex arithmetic than just adding and subtracting. The BERT Revolution, invented by Jacob Devlin and his colleagues, was used to map words to embeddings, allowing for real-world correspondence in arithmetic. This concept was later used in Google's Featured Snippets, which was revamped to use embeddings and the Bert revolution. David's lecture at Boston University, which is titled "Natural Language Understanding, Deep Learning and the BERT Revolution" discusses the underlying mechanics of natural language processing and how it transformed problems in language into arithmetic. The BERT Revolution allowed for more complex arithmetic than just adding and subtracting, making it easier for neural networks to perform complex tasks.  The Rise of Hidden Markov Models David talks about the state-of-the-art technology at the time, Hidden Markov models, which had a temporal aspect of a changing probability distribution. These models were based on the sequence of text, and the Bayesian reasoning was used to determine the most likely audio to come from the words. This led to the development of generative models, where words generate the audio through probabilistic models. However, Bayesian modeling has been replaced by deep neural nets in the last five years of generative AI. He mentions that, in the early days, neural networks were untrainable and unwieldy, making Hidden Markov models the Bayesian generative approach. However, deep neural networks are now used. The Development of Neural Networks David discusses the development of neural networks, a technology that has been around since the 1950s. The availability of more recordings for speech, text, and language models has made it more accessible on the hardware side. The core of a neural network computation is matrix multiplication, which has been addressed by Nvidia and Google with their TensorFlow units. These units have invested large amounts of money in making specialized, custom hardware for this problem, accelerating things. David talks about how algorithms have also advanced significantly since the 1950s, and mentions key factors that have aided the advancement.    Becoming an Individual Contributor at Google David talks about how he learned the technology. He decided to become an individual contributor and studied the technology, the code, the papers, books, videos, and experiments. He spent most of the pandemic working on neural nets that eventually became the Gemini technology. David's journey to becoming a knowledgeable and skilled individual in neural networks was a journey that took him from a theoretical interest to a practical application. He learned to make the most of the technology and its capabilities, ultimately contributing to the advancement of the field. David has faced mixed reactions to his decision to become an independent contributor at Google. While some were supportive and skeptical, others were skeptical. He talks about the advice he received, how he moved forward, the success rate of his projects, and how his career has decelerated since 2019.  Behind the Curtain of French Theater The discussion moves to French theater and how David has become a French theater producer. He shares his journey of starting a production in Boston from scratch. To start a French theater production in Boston, David had to be integrated into the French community in Boston and the theater community in Boston. They do not create the theater but bring the original production to Boston and add subtitles. He talks about the challenges faced in securing locations, staff and equipment, and managing the production process such as hiring a director, actors, space, marketing, and logistics. He uses services like Playbill to manage administration, program design, publicity, and logistics. He is passionate about creating a new cultural institution in Boston that focuses on French theater. Boston is known for its strong ties to France and hospitals, and David aims to create a French theater festival or translate French theater into English. He works with the French American Chamber of Commerce of New England, which helps create businesses and connections in Boston. Behind the Screen of Girls Who Code David has worked with Girls Who Code, an after-school program that runs programs for young women interested in programming and technology. He organized a meet-up at Google's Cambridge office, where he gave a keynote speech at parent meetings, emphasizing the importance of belonging and ownership in the industry. He was able to connect with 150 teenage girls and their parents, who expressed gratitude for his message. David's involvement with Girls Who Code has led to a sense of belonging and empowerment for these young women, who are now more likely to pursue careers in the tech industry. He believes that the French language theater in Boston could potentially sustain them through a 25-year career in the industry. Influential Harvard Professors and Courses David shares his experiences as a TA in the math department and working with Deborah Hughes Hallet, who was running a calculus project. David's theater experience has played an ongoing role in his teaching approach, as he learned from her dedication and approach to teaching. He believes that the notion of understanding the world through teaching is a deep-rooted belief in his approach.  Timestamps: 03:59: Professional Career and Industry Experience  06:52: Non-Professional Activities and Community Involvement  11:22: Technological Advancements and AI Overview  25:07: Transition to Individual Contributor Role at Google  30:17: French Theater Project and Community Building 40:39: Impact of Girls Who Code and Teaching  45:25: Final Thoughts and Contact Information  Links: Theater: www.frenchtheaterproject.com Theater Club: https://frenchlibrary.org/french-library-theater-club/ Website: www.monsieurmiller.com LinkedIn: https://www.linkedin.com/in/davidrhmiller/ David's  2019 lecture "Natural Language Understanding, Deep Learning and the BERT Revolution" at Boston University : https://www.youtube.com/watch?v=DktFhgxynFE Featured Non-profit This week's featured non-profit is the Cure San Filippo Foundation recommended by Adam Shaywitz who reports: “Hi. I'm Adam Shaywitz, class of 1992 the featured nonprofit of this episode of The 92 report is the Cure San Filippo Foundation. This organization is dedicated to advancing treatment options for children affected by the devastating childhood dementia known as San Filippo syndrome. I am privileged to serve as a board member for the past five years. You can learn more about their work at Cure Sanfilippo foundation.org, that's one word. Cure Sanfilippo foundation. San Felippo is spelled s, a, n, f, i, L, i, p, p, O, that's 1f, 1l, and 2p Cure San Filippo foundation.org, and now here is Will Bachman with this week's episode.” To learn more about their work visit: www.CureSanFilippoFoundation.org.

Send us a Text Message.Coping with a tooth cavity is a universally dreaded experience.But what if we could detect and treat them before they cause trouble?In this week's HealthBiz Brief, Jordan Rubinson, CEO of Cavisense, elucidates how their technology detects cavities early, aiming to prevent tooth decay, safeguard oral health, and potentially reverse damage.

In this episode of "People Solve Problems," Jamie Flinchbaugh hosts Frank L. Douglas, CEO of Safe Haven Dialogues. Frank brings a wealth of experience as a former Executive Vice President and Board Member of Aventis, now Sanofi, and shares insights from his storied career in the pharmaceutical industry and beyond. Currently, Frank leads Safe Haven Dialogues, an organization dedicated to addressing issues of discrimination and conflict through their innovative Reframing Methodology. Frank discusses his recent book, "Until You Walk in My Shoes: A Reframing Methodology to Overcome Systematic Discrimination," which offers a unique approach to tackling discrimination and fostering inclusion. He shares a compelling story from his tenure as the Global Head of Research and Development for Marion Merrell Dow, which was acquired by Hoechst AG and later merged with Rhône-Poulenc Rorer to form Aventis. Faced with the challenging task of merging pipelines and downsizing, Frank chose a collaborative approach, involving the heads of research from the merging companies to set evaluation criteria together. This method ensured that decisions were made fairly and transparently, emphasizing the importance of shared criteria and collaborative decision-making. One of the central themes Frank explores is the concept of reframing. He recounts a personal experience at Xerox, where he faced discrimination early in his career. Initially frustrated by being overlooked for projects, Frank realized that reframing his approach—focusing on getting assigned to a good project rather than merely highlighting discrimination—could lead to more productive outcomes. This insight laid the foundation for the Reframing Methodology he advocates through Safe Haven Dialogues, where the focus shifts from individual grievances to finding solutions that benefit the broader team or organization. Jamie and Frank also discuss the broader implications of this methodology in organizational settings. Frank highlights the critical roles of equity and inclusion in any organization. By examining the culture through the lenses of equity (values and principles) and inclusion (behaviors and actions), organizations can identify and address disparities more effectively. Frank emphasizes the importance of understanding the aspirational culture (what the organization strives to be), the actual culture (what is practiced), and the experienced culture (what individuals feel). Their discussion also touches on the challenges of implementing these concepts in practice. Frank acknowledges that while leaders can set aspirational cultures, the real impact often comes from frontline managers who shape the day-to-day experiences of employees. Therefore, addressing issues at the experiential level is crucial for achieving equitable outcomes. Throughout the episode, Frank's passion for empowering individuals and fostering inclusive environments is evident. He provides practical insights and actionable strategies for leaders and individuals alike to reframe challenges and work towards more equitable solutions. His stories and examples illustrate the power of collaborative problem solving and the importance of aligning personal and organizational goals. To learn more about Frank L. Douglas and his work, visit safehavendialogues-llc.com. Connect with Frank on LinkedIn at linkedin.com/in/dr-frank-l-douglas. Additionally, you can find his book, "Until You Walk in My Shoes: A Reframing Methodology to Overcome Systematic Discrimination," on Amazon. This episode of "People Solve Problems" is a must-listen for anyone interested in leadership, DEI, and practical solutions to organizational inclusion challenges. Through engaging stories and thoughtful discussion, Jamie and Frank provide valuable perspectives on how to navigate and overcome complex issues in today's workplaces.

Our latest episode features Marcin Majewski, Founder and Managing Director of Aventis Advisors, an M&A advisory firm focusing on technology and growth companies, who shares his insights and experiences from the front lines of technology mergers and acquisitions. Recently, Aventis Advisors launched comprehensive research on valuation trends and multiples in the Public and M&A market for SaaS companies.In this episode, we dive deep into Marcin's research and discuss:• How does the current market environment impact tech M&A valuations, and what should investors consider?• The differences between public and private multiples.• Why are SaaS businesses valued higher than on-premise software businesses, and how have their premiums changed recently?• How the "small company discount" market valuation trends.• Valuation Drivers: How does business size affect valuations, and what factors contribute to higher valuations for larger companies?• Valuations from private deals vs. those from public markets.• Revenue multiples vs. EBITDA multiples.• How should founders approach understanding their company valuation.Like the episode? Subscribe and don't miss out on the next one!

"Watkins đã cung cấp một lộ trình hoàn hảo, chi tiết về những điều mà một người lãnh đạo mới cần biết để đẩy nhanh quá trình học hỏi và thành công trong vai trò mới. Cuốn 90 Ngày Đầu Tiên Làm Sếp này cần phải được đưa vào chiến lược phát triển lãnh đạo của mọi công ty, để mỗi người nắm bắt công việc nhanh chóng và khéo léo hơn khi chuyển sang vị trí mới trong tổ chức” - Suzanne M. Danielle, Giám đốc Phát triển Lãnh đạo toàn cầu của công ty Aventis.Hằng năm, rất nhiều nhà quản lý trong các tập đoàn lớn được đưa lên làm lãnh đạo. Dù nhiệm vụ mới là quán xuyến một đội nhóm hay tiếp quản công ty với chức danh CEO, họ đều phải đối mặt với những thách thức giống nhau trong những tháng đầu tiên. Trong cuốn sách này, Michael Watkins - chuyên gia nổi tiếng về kỹ năng lãnh đạo, đưa ra các chiến lược đã chứng minh được độ hiệu quả, qua đó giúp chúng ta thành công ở vai trò mới, tại bất kỳ thời điểm nào trong sự nghiệp. --Về Fonos:Fonos là ứng dụng sách nói có bản quyền. Trên ứng dụng Fonos, bạn có thể nghe định dạng sách nói của những cuốn sách nổi tiếng nhất từ các tác giả trong nước và quốc tế. Ngoài ra, bạn được sử dụng miễn phí nội dung Premium khi đăng ký trở thành Hội viên của Fonos: Tóm tắt sách, Ebook, Thiền định, Truyện ngủ, Nhạc chủ đề, Sách nói miễn phí cho Hội viên.--Tải ứng dụng Fonos tại: https://fonos.app.link/tai-fonosTìm hiểu về Fonos: https://fonos.vn/Theo dõi Facebook Fonos: https://www.facebook.com/fonosvietnam/Theo dõi Instagram Fonos: https://www.instagram.com/fonosvietnam/Đọc các bài viết thú vị về sách, tác giả sách, những thông tin hữu ích để phát triển bản thân: http://blog.fonos.vn/

Welcome to The Voice of Retail. I'm your host Michael LeBlanc. This podcast is brought to you in conjunction with Retail Council of Canada.In this episode, meet Howard Tiersky, Author of the Wall St.Journal best-selling book, Winning Digital Customers: The Antidote To Irrelevance.  In a wide-ranging interview with this digital veteran, Howard takes us through his five-step roadmap to thriving in a digital world.Thanks for tuning into this special episode of The Voice of Retail.  If you haven't already, be sure and click subscribe on your favourite podcast platform so new episodes will land automatically twice a week, and check out my other retail industry media properties; the Remarkable Retail podcast, the Conversations with CommerceNext podcast, and the Food Professor podcast.  Last but not least, if you are into BBQ, check out my all new YouTube barbecue show, Last Request Barbeque, with new episodes each and every week!I'm your host Michael LeBlanc, President of M.E. LeBlanc & Company & Maven Media, and if you're looking for more content, or want to chat  follow me on LinkedIn, or visit my website meleblanc.co!  Have a safe week everyone!I'm your host Michael LeBlanc, President of M.E. LeBlanc & Company & Maven Media, and if you're looking for more content, or want to chat  follow me on LinkedIn, or visit my website meleblanc.co!  Have a safe week everyone! About HowardI've had the amazing opportunity to help leaders at dozens of the world's largest brands navigate digital transformation—to re-invent their customer journeys to earn the love of today's "Digital Customers." I've learned so much after 20+ years doing this type of work and I'm excited that my most recent book was named on the WSJ Best Selling list. It's called WINNING DIGITAL CUSTOMERS and is a blueprint for how any company can methodically remake itself to win in a digital era. In it I reveal the methods I've developed to get alignment at large organizations around transformation and then to implement it successfully. If you'd like to check out a few sample chapters just IM me.It's been an incredible journey. I spent 15 years leading digital practices at 2 of the world's largest consulting firms. Then 12 years ago I decided to leave a senior role at Capgemini to start my own firm, initially with 1 client and 0 employees. My wife was quite concerned about that decision! She's happy now though, as the company has grown to over 75 amazing people working with large brands like Verizon, NBC, Avis, A&E, Mattel, AAA, & Airbus. We've won many awards but more importantly have driven massive and measurable value through helping transform our client's customer experiences. I speak regularly at conferences such as The Front End of Innovation, DMA, Internet Week, and CES. I also publish frequently and have been a contributor to CIO magazine. I was named by IDG as one of the "Top 10 Digital Transformation Influencers," & by Enterprise Management 360 as “One of the Top 10 Digital Transformation Influencers That Will Change Your World.” I was also honored to be featured on a 1 hr video program with the Harvard Business Review, and I've served as an adjunct professor at the NYU graduate school.Other brands I've worked with include: Turner, Sprint, Office Depot, Farmers, CNA and Mercury Insurance, Sears, Merrill Lynch, GM, Amex, CBS, Allstate, Amazon, Mastercard, Sylvania, Merck, Aventis, Houghton Mifflin, Universal Studios, Wiley, Viacom, Crayola, Mcgraw-Hill, Nutrisystem, NFL, NBA, Visa, Shubert, Moodys, Morgan Stanley, Gulfstream, Exelon, GMAC, Fox, Chevron, D&B, Bloomberg, Sesame Workshop, Barnes & Noble Education.I live in NJ with my wife Lana & my 5 children...or I guess I should say 4 of my children..my oldest, Rachel, left this year to begin her freshman year at Dartmouth. If you are at an enterprise looking to transform and win digital customers, please connect with me, and we can schedule a call to explore whether and where my team and I can be of help. About MichaelMichael is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice. He brings 25+ years of brand/retail/marketing & eCommerce leadership experience and has been on the front lines of retail industry change for his entire career. He has delivered keynotes, hosted fire-side discussions with C-level executives and participated on thought leadership panels worldwide.  Michael was recently added to ReThink Retail's prestigious Top 100 Global Retail Influencers for a second year in  2022. Michael is also the producer and host of a network of leading podcasts, including Canada's top retail industry podcast, The Voice of Retail, plus the Remarkable Retail with author Steve Dennis, Global E-Commerce Tech Talks and The Food Professor with Dr. Sylvain Charlebois.  Most recently, Michael launched Conversations with CommerceNext, a podcast focussed on retail eCommerce, digital marketing and retail careers - all available on Apple, Spotify, Amazon Music and all major podcast platforms.   Michael is also the producer and host of the “Last Request Barbeque” channel on YouTube where he cooks meals to die for and influencer riches.

Née au Congo-Brazzaville, Yolaine Eleka-Vienne est arrivée en France pour poursuivre ses études. Elle obtient en 2001 un master en administration et gestion des affaires et des entreprises. S'ensuit un parcours semé d'embûches pour accéder à l'emploi : malgré cela, Yolaine persévère et intègre des grands groupes (Calors, Bayers, Aventis, etc.). Après 13 années d'expérience dans les fonctions supply chain, service client et analyst stock, elle devient responsable de l'ONG Mwana Villages. Titulaire d'un MBA Entrepreneurship & Innovation, elle décide de cofonder une entreprise engagée et responsable : Keyaa voit le jour en décembre 2021. La société fabrique depuis Lyon 3 gammes de produits : des granolas, des tisanes et des poudres à base de superaliments africains (le baobab, l'hibiscus et le moringa). L'entrepreneuse nous raconte son parcours et sa façon de concevoir l'entreprise.

Marcin Majewski to założyciel Aventis Capital – butiku M&A, który pomaga sprzedawać założycielom i kupować grupom kapitałowym spółki na całym świecie. W podcaście rozmawiamy o momentach, w których warto rozważyć sprzedaż firmy, o przygotowaniach spółki do przejęcia, aby wycena była jak najwyższa, o kluczowych umiejętnościach eksperta od M&A, oraz o tym, co jest ekscytującego w tej branży i jakich inwestorów warto obserwować.

Philippe Auvaro is the former President of OrphanPacific Inc. of CMIC Holdings. Being born in the 60s, Mr. Auvaro grew up in a generation when Japan was experiencing the economic boom. He developed an appreciation of Japanese culture including classic movies, leading him to apply to an internship at a French pharmaceutical company called Roussel. Mr. Auvaro was eventually hired as a full-time staff at Roussel based in France, then worked for Aventis, which had gone through a merger with Sanofi in France. As Mr. Auvaro wanted to return to Japan, he then joined Glaxo SmithKline (GSK) Japan where he eventually became Executive Director. Most recently, Mr. Auvaro was the Managing Director, Senior Executive Officer of CMIC Holdings and President & Representative Director at OrphanPacific, Inc.   At GSK, Mr. Auvaro started as a Deputy Director in the Sales Division. He calls these years the “most amazing 11 years” of his life as he calls the organization “a school of empowerment.” Prior to his leadership role at GSK, Mr. Auvaro has experience in moving through the traditional Japanese management style ranks as well as working in a multicultural environment in both Europe and Japan. Mr. Auvaro explains his true “cross-cultural leadership experience” came when he was promoted to lead Roussel (which at that point had merged into Hoechst Marion Roussel) in Taiwan where he created the local office from scratch   Mr. Aurvaro's first major leadership role at GSK was leading a mega product for an antiasthma inhaler. There, Mr. Auvaro says he gained “field leadership” experience by working with people from various cultural background at the ground level, being in contact with every single part of the organization including manufacturing, R&D, and digital technology. Mr. Auvaro helped set up business units and create a shared service structure for the commercial operations such as helping start market research and call centres. Mr. Auvaro then got a secondment from GSK to work for Aspen PharmaCare, headquartered in South Africa, and was asked to help start Aspen in Japan.   After GSK, Mr. Auvaro was offered his most recent position at CMIC Group as OrphanPacitic Company's leader through a personal connection. At CMIC, Mr. Auvaro had been working on providing pharmaceutical solutions for rare disease challenges.   Mr. Auvaro describes his leadership as more “hardware than software” as he leans more towards directive leadership than being the recently popular “servant leader” type. Mr. Auvaro loves to be involved in the technical side of any product or service development and calls himself a fact-driven, field person. Mr. Auvaro defines leadership as a transaction between the leader and the employees. He says: “there is a fair amount of trust and delegation that people put in you. So you need to measure and scope and accept it, or redefine the scope.”

In this episode we speak with Dr. Errol De Souza, PhD, Executive Chairman of the Board of Directors at Bionomics.  Bionomics just raised nearly $16mm to conduct clinical trials on their revolutionary drug to treat PTSD.  Dr. De Souza is one of the premier entrepreneurs in the biotech space with a special focus on development of therapeutics for treatment of Central Nervous System disorders. During his career as an entrepreneur, Dr. De Souza has raised several hundred million dollars in capital in both private and public markets and has taken companies public (Neurocrine Biosciences IPO) and sold companies (Synaptic sale to Lundbeck). Over Dr. De Souza's career, he has served in a number of high-ranking R&D roles, including SVP and U.S. head of Aventis (1998-2002), co-founder and EVP of R&D at Neurocrine (1992-1998) and Head of CNS at DuPont Merck (1990-1992). Dr. De Souza is currently a Director of several public and private companies and currently serves as a member of the board of directors of Catalyst Biosciences (CBIO). He has previously served on the board of directors of several public companies including IDEXX Laboratories (IDXX), Neurocrine Biosciences (NBIX), Palatin Technologies (PTN) and Synaptic Pharmaceuticals (SNAP).  HERE ARE SOME OF THE THINGS WE TALKED ABOUT: De Souza shares his background and how it led him to the biopharmaceutical industry. We discuss what goes into the process of developing a drug for the Central Nervous System and ways that this process is the same and different from the development of other pharmaceuticals. De Souza discusses the two categories of disorders that come from the Central Nervous System, psychiatric and neurological, and the drug development history of the two dating back to the 50’s. We talk about the story behind Bionomics, their new compound BNC210 which is used for the treatment of PTSD which received a “Fast Track” designation from the FDA. De Souza helps us break down exactly what is PTSD, how it occurs, what’s going on in the brain and talks about how we can use that knowledge to develop biopharmaceutical treatments for PTSD (which is what Bionomics is leading the way on right now). He talks about current PTSD treatments and their shortcomings as well. We talk about the Bionomics collaboration with Merck which uses similar compounds in the clinical treatment of cognitive deficits in Alzheimer’s disease and why there are similarities between Alzheimer’s and PTSD based on the neurochemistry of the brain. Finally, Dr. De Souza gives some advice for entrepreneurs who are starting out early in their career and investors that are coming into this space who lack the background knowledge. Connect with the Stigma Podcast in the following ways: Patreon, Website, Twitter, Facebook, LinkedIn, Email Connect with host Stephen Hays here: Stephen Hays Personal Website, Twitter, LinkedIn, What If Ventures (Mental Health Venture Fund)    

Ein gutes Finanzjahr beginnt mit einem optimistischen Konjunktur- und Kapitalmarktausblick. Genau den gibt´s in der ersten Episode der Geldmeisterin von Martin Kocher, Leiter des Instituts für höhere Studien, Präsident des Fiskalrats und Berater der österreichischen Bundesregierung. Bei der Geldmeisterin zu Gast ist auch Börsenexperte Wolfgang Matejka, Geschäftsführer von Matejka und Partners Asset Management, der Anlagetipps für 2021 bei einem positiven Kapitalmarktumfeld gibt. Außerdem erfährst Du worauf aktuell die Anlegerlegende Warren Buffett setzt. Am Ende serviert Dir die Geldmeisterin noch ein nachhaltiges Extra-Anlagezuckerl, den Indexfonds. ishares Global Clean Energy ETF (A0MW0M | IE00B1XNHC34), der den Wert der 30 größten Unternehmen weltweit im Bereich saubere Energie nachbildet - wie immer keine Anlageempfehlung, sondern nur die persönliche Investment-Meinung der Geldmeisterin. Besprochen werden außerdem die Aktientitel Hoch Tief, Geresheimer, Sanofi, Aventis, Berkshire Heathaway Gutes Gelingen bei der Vermehrung Deines Vermögens und ein lebenslanges gutes Leben wünschen Dir die Geldmeisterin und ihr alter Ego Julia Kistner MUSIK- & SOUNDRECHTE Silly Intro by Alexander Nakarada _ Is anyboddythere by 8er41 _TEC Money/Coins/Dice by tec_5 Donkey braying 1 (ID 1549) --- Send in a voice message: https://anchor.fm/geldmeisterin/message

We discussed a number of things including: 1. How to lead in a time of great uncertainty 2. Raising funds and managing teams during a downturn 3. What he's seeing in biotech and biopharma sectors Francois Nader, MD, is a leading value builder in the biopharma industry. Dr. Nader currently serves as chairman of Acceleron Pharma (XLRN), Prevail Therapeutics (PRVL) and Talaris Therapeutics; and board director of Alexion Pharmaceuticals (ALXN) and Moderna (MRNA). Previously, Dr. Nader was President, Chief Executive Officer and Executive Director of NPS Pharma from 2008 to 2015. During his tenure as CEO, Dr. Nader transformed NPS Pharma into a leading global biotechnology company focused on delivering innovative therapies to patients with rare diseases. The company was acquired by Shire for $5.2B in 2015. Dr. Nader won the Ernst and Young National Life Science Entrepreneur of the Year® award in 2013. Before NPS, Dr. Nader was a venture partner at Care Capital. Prior, he served on the North America Leadership Team of Aventis and its predecessor companies holding a number of executive positions including senior vice-president, integrated healthcare markets and North America medical and regulatory affairs. Previously, he led the global commercial operations at the Pasteur Vaccins' division of Rhone-Poulenc. Dr. Nader is past chairman of BioNJ, New Jersey's biotechnology trade organization and has served on the board of the Biotechnology Industry Organization (BIO) and as independent director of Clementia Pharmaceuticals (CMTA) acquired by IPSEN for $1.2B in 2019, Advanced Accelerator Applications (AAAP) acquired by Novartis for $3.9B in 2018, Baxalta (BXLT) acquired by Shire for $32B in 2016, Trevena (TRVN) and Noven (NOVN) acquired by Hisamitsu for $459M in 2009. Dr. Nader earned his French Doctorate in Medicine from St. Joseph University (Lebanon) and his Physician Executive MBA from the University of Tennessee.

On the podcast this week is Dr Jonathan Sackier, MB, ChB, FRCS, FACS who is an internationally renowned surgeon, technology innovator and entrepreneur. Trained in Britain as a surgeon and recruited to the USA in 1989 he helped lead the laparoscopic surgery revolution. As a Professor at George Washington University in Washington, DC, he founded, and funded the Washington Institute of Surgical Endoscopy, a center for education, research & innovation. He is a Visiting Professor of Medicine & Surgery at the University of Virginia and his activities in basic and clinical research funded by multiple grants have led to many publications, chapters and books. He has served multiple journals as editor or reviewer, has been involved in medical societies at the highest level and has been honored for his work in many countries. Jonathan's collaborations with the pharmaceutical and medical device industry have resulted in technologies that have been brought to market with partners like Valleylab, Pfizer, Karl Storz, Applied Medical and Pall. In 1984 his team at Genethics discovered and patented a line of amniotic stem cells and then licensed the rights to a publicly traded British drug discovery company. He helped develop and bring to market the AESOP robot with Computer Motion, who had a successful IPO in 1997 and has also started a medical products contract sales organization, a locum medical agency and a communications company. He has consulted to many companies including Aventis, Cook, Integra Neurosciences, Bayer, Cryocath, Novartis and ConvaTec and has worked with the financial community on enterprise financing, mergers & acquisitions and due diligence. A frequent commentator in the media, Jonathan has been a guest on radio and television many times to discuss various healthcare issues. In the mid-1990's he hosted a television health magazine program “Health and Wellness” aimed at a senior audience for the Goodlife Cable TV network and served the communications company Spotlight Health with their celebrity featured outreach including the hugely successful Carnie Wilson web-cast which drove increased attention to bariatric surgery as an option for the management of morbid obesity. Jonathan has served the National Committee of the Steppenwolf Foundation, is a Trustee of the First Star Foundation, the Virginia Hillel Board and previously chaired the Board of the Larry King Cardiac Foundation. He has sat on the Associate Board of AdvaMed (the medical device industry trade association) and on several corporate and scientific advisory boards.

Today we meet one fo the many heroes that make up the Stormcast Eternals, Aventis Firestrike! Click Here to Join My Community on Patreon! https://www.patreon.com/twoplustough Get An Awesome Shirt Here: https://teespring.com/stores/2tough-s... Follow me in other fun places! Twitter: https://twitter.com/tough_up Facebook: https://www.facebook.com/TwoPlusTough/ Instagram: https://www.instagram.com/2uptough/ Discord: https://discord.gg/efdZEXE   Music: "Lost Time" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/b.

Brought to you by OnPay. Built in Atlanta, OnPay is the top-rated payroll and HR software anywhere. Get one month free at OnPay.com. Tom Lasswell is Vice President of IT Operations at Aventis Systems. Tom is an industry veteran with over 17 years of IT experience in various industries. Having had an opportunity to work […] The post Tom Lasswell with Aventis Systems appeared first on Business RadioX ®.

Janet Shapiro has over 25 years of experience working in public relations, business development, human resources and marketing in pharmaceutical, healthcare, device, non-profit organizations. She has also done work with C-Suite-level, expert cultivation campaigns and authors with diverse disciplines. With a mission to provide top senior-level public relations counsel to corporations and non-profit organizations, Jan has worked both independently and with teams of other senior counselors on a variety of client matters including company and personal branding. Some of her high-profile media placements include features with MSNBC, CNBC, CNN, FOX, TIME, USA Today, US News & World Report, Washington Post, New York Times, Chicago Tribune, Wall Street Journal, Forbes, Fortune Entrepreneur, INC O, The Oprah Magazine, Elle, Self, People, Steve Harvey, and TODAY Show. Corporate clients Jan has worked with include Aventis, Bayer, Schering-Plough, Glaxo -Wellcome, Pfizer, Quest Diagnostics, Kaplan Clinic, Sams Club, Revlon, Colony Group and Masterpiece Living along with over 125 individual personality cultivation campaigns. What you'll learn about in this episode: Jan and Sue's professional journey together The importance of being able to speak out and find support during difficult times What it means to lead with intuition in your personal and professional life Sue's perspective on work-life balance vs. work-life integration How to manage your time as you chase perfection Vision, traction, and health in your organizational success Resources: Website: https://www.smithpublicity.com/ LinkedIn: https://www.linkedin.com/in/janet-shapiro-4591b152/ https://www.linkedin.com/company/smith-publicity-inc./ Facebook: https://www.facebook.com/SmithPublicity Twitter: @SmithPublicity The Unf

Palestrante, engenheiro e piloto conhecido por liderar a equipe que conquistou 18 pódios durante os 25 anos que representou o Brasil no Rally Dakar. Com nossa equipe já realizou mais de 1.000 trabalhos (palestras, atividades experienciais, team building e treinamentos) para empresas como Abbott, Alcoa, Arthur Andersen, Aventis, BB, Bradesco, Itaú, Santander, Basf, Bosch, BRF, Bunge, Citroën, Claro, Coca-Cola, CVRD, Duratex, E&Y, Embratel, Faber Castell, FGV, Ford, Gerdau, Gessy Lever, Grupo Algar, HP, IBM, Janssen Cilag, Kraft, Lenovo, Lojas Pernambucanas, Mahle Metal Leve, Mercedes-Benz, Monsanto, Nestlé, Novartis, Oracle, Pão de Açúcar, Petrobras, Pirelli, Porto Seguro, P&G, Redecard, Renault, Rhodia, Roche, Saint Gobain, Samsung, Santista Têxtil, Schering-Plough, Shell, Siemens, Sony Ericsson, Sul América, Sun, Syngenta, Telefônica, Ticket, Tigre, TIM, 3M, Unilever, Vivo, Volvo, Votorantim, VW, além de escolas e universidades, e muitas outras empresas. Suas participações estimulam o protagonismo e o trabalho em equipe, em benefício da velocidade com responsabilidade, do planejamento que viabilize a eficácia consistente. Nós encorajamos a resiliência e o estabelecimento de um ambiente de confiança. O objetivo é colaborar no desenvolvimento de habilidades como: 1. Pensamento crítico e resolução de problemas; 2. Adaptabilidade e flexibilidade; 3. Comunicação; 4. Liderança; 5. Inovação e criatividade. Realiza consultorias e participo de projetos que utilizam energias renováveis, dentro e fora das pistas. Escreveu três livros: - Rally Paris-Dakar – O Vírus do Deserto, - Grãos de Areia – 8 anos de aventuras no Rally Paris-Dakar, - Rali – Abrindo os caminhos do Brasil. Também tem participação em outros livros e escrevo artigos para revistas, jornais e sites na internet. Comentarista dos canais esportivos da ESPN desde 2007, com blog no site da ESPN Brasil 

Hey everyone, welcome to the overview episode of the Launch and Scale Podcast. I'm Khierstyn Ross, and I am so excited to be officially kicking this off. For those that have been following the Crowdfunding Uncut podcast for a while, you know that I did that for the last three years where that podcast focused really heavily on how to bring physical products to market through the Kickstarter route. Over my last four years being in the trenches with creators, really bringing products to market, managing very large crowdfunding campaigns of multiple six-figures, and advising E-commerce brands on how to bring new products to market, I felt that it was time to evolve the brand. And really evolve the conversation to taking everything I've learned from the Kickstarter route, and bringing products to market successfully, and really applying that to any product launch online. Because what I've noticed is with Kickstarter launches you have one chance, really, to make a great first impression. You have one chance to position your product properly, one chance to make sure that your message is right, the pricing is right, and not only that, but that you have an intimate understanding of why your customer is going to buy this product so that you can have a great sales message, a great video and all that. What I've found is that with Kickstarter campaigns, because it is, traditionally, people have a very high failure rate on Kickstarter whereas the success rate on Kickstarter's about 37%. The big factor with that is to make sure that you not only have an audience of people ready to buy your product when you're live but the other side is making sure you have the right audience because you want to make sure you're building up the right audience of people that are actually going to resonate with your product and love your products so that they buy it on your Crowdfunding campaign when it goes live. And so because of that and because of the whole getting to know your customer and how much it builds into positioning your product properly, I find that the work that we've done and why I have such a high success rate of campaign success on Kickstarter is because we do a lot of due diligence leading up to a launch of who is your customer. Let's prove that hypothesis through Facebook marketing, let's prove that hypothesis through customer interviews through a structured beta test, which we talk about in episode two, and through different things like that to really make sure that the assumptions we make about our product and who is going to buy and why people love it, we make sure that that is market tested and proven so that when we go to spend so much time and resources launching this product that we get it right the first time. So, I've found that after working with beginner brands who were using Kickstarter for launch that first product versus an eCommerce client that maybe selling a dozen or so products on Amazon and they know want to build up their audience using Kickstarter as an addition platform, I noticed a trend in that the things we do so early stage with beginner brands to really scope who the customer is, market test demographics and make sure that they are predictably setting up the way we position our product. I realized that that in a lot of the eCommerce brands like the current ones that we approaching me didn't have that locked in. So, I thought, okay, well, I want to take this conversation more mainstream and everything that we have done with Kickstarter campaigns to make sure that we have a six-figure launch, to make sure we are positioning the product and the message we have really resonates with the person we put it in front of. I wanted to take that conversation more so that people who are looking at taking their product off of Amazon and selling on their Shopify site or building a physical product or even looking to create that round two of a product for a launch, if you're on the Kickstarter side of things, you can use this information to make sure that you are going to have an even more successful product launch. So, what we're covering in Launch and Scale Podcast is, really, how to build a strong foundation for your eCommerce physical product even if you're using Kickstarter, you're using Amazon or whatnot because ultimately there is a reason why I've had such a strong track record bringing products to market and I want to make sure that information is available to more of you guys. So, what you can expect of this podcast where Crowdfunding Uncut was heavily focused on the interview side of things, this time around it's going to be a less formal approach. So I'm looking to doing a mix of shorter episodes where it will be led by questions submitted by the audience or I'll do a 10 to 15-minute segment on answering that question. We'll be doing behind the scenes experiments. If there is a topic through an expert that I want to bring on then we will do a more long-form interview. So, the format is going to be loose, it's going to evolve with the show and evolve with feedback. What I've done is I've created the first few episodes off of questions that were emailed in from the Crowdfunding Uncut family. So we're in for a really juicy start. Thank you so much for your support. If this is the first time listening to the Launch and Scale Podcast, please be sure to head over to khierstyn.com/podcast and in there you will be able to select iTunes or Stitcher and go in and subscribe to the show. And if you love the content, please do leave an honest review of the show. It does help other people think the content that is helpful for them and their unique situation. My name is also impossible to spell so it's K-H-I-E-R-S-T-Y-N.com/podcast. Apart from that, if you are not familiar with my story and how the heck I got into product launches, this is where I'm going to talk about that. So, about four and a half years ago, I went to a networking event and I had a little bit of experience online and I ran into this founder of this quirky product that he eventually sold me on it and he got the idea, because we were talking about Matt Ward from Art of the Kickstart before he sold it to Aventis with Roy [Morjan 00:06:47], and a few days later, Adam came back to me and he's like, "Hey, so this product, I've been thinking more about it and I want to bring it to Kickstarter." And I was like, "Huh, interesting. I don't know anything about Kickstarter." And so the conversation goes back and forth, he's like, "No, no, no, I think it could be really good if we partnered up on this. You know the marketing side of things and I'm the product creator. A perfect world." I was like, "Okay, cool." So, eventually, a few weeks go by and I commit to helping him market this product. And we go and we spend about three months preparing for it, really not knowing anything of what we were doing and if what we were doing was right and we went up to this launch. And that very first launch we did on Indiegogo and it was an absolute disaster. We made every mistake in the book but at the time we didn't know that. So we pressed the launch and then nothing happened. So, over I think it was a 34-day campaign we ended up failing horribly so we set our goal at $50,000 and by the end, we only raised about $17,000. It was a disaster, to say the least. After that campaign failed we had two options. We could quit and pack up shop or we could really explore and see what we did wrong. After feedback from a few marketing professionals, we realized that it actually wasn't the product. The product was pretty good and it was most likely to sell. What was wrong was how we approached the campaign. So we used that time, about four months, to readjust and redo our marketing plan. So we realized where we went wrong was a classic mistake. On Kickstarter, you have to go in with an audience of people ready to buy so that the algorithm picks you up and shows you to more people and creates a snowball effect. So there's that. But the other thing is we completely butchered the product positioning. Here we were, two skinny people, trying to sell a weight loss product in an industry that neither of us really understood and we didn't take the time to really talk to our customer and get to make sure that the product positioning and I guess the sales pitch and the video we'd put together to make sure that it was actually in alignment with what would get people to buy and it really wasn't. So we took this feedback and we ended up going to our market, getting feedback to completely change our product positioning and building up an audience. So we did those two things really differently, really focused on that for the next three to four months and then we relaunched that product. And when we launched it, that time, the thing explodes. We end up raising just shy of $600,000 on Indiegogo for this product. And that really launched my career. I was in denial at the time because I was like, "I hate Kickstarter. I don't want to do it." But it's funny because a couple of months after that point, I was forced to do a talk in Toronto because the founder didn't want to do it and so I did the talk on the transition between how we went from a $17,000 failure to a $600,000 success. And there was the founder of my second official campaign or client in the audience, David from Tapplock. And he's like, "I really like what you did with this product. Can we talk?" And so I ended up working with Tapplock and that was my second big win where Tapplock went and raised $342,000 on Indiegogo. And then from that, I got partnered up with Maneesh Sethi of Pavlok where we launched the Shock Clock 2 and that ended up doing another $350,000. And then I eventually met Chris from Jam Stack. Again, he's one of my most talked about case studies. We did an $82,000 launch and then a $362,000 launch and it just kind of went from there. So, that's when, about three years ago, I committed to niching completely into Kickstarter Indiegogo launches and built the podcast and really here we are today. So, over the time that I've spent in the trenches in the last four years, I've had some major wins bringing physical products to market. I've been in the trenches with people and success speaks for itself and that's really my backstory. If we ever get on a call, if you're listening to this, if you want to find a little more information, happy to share but that's kind of like the Cliff Coles Notes version of what the brand was with Crowdfunding Uncut and the reason I've decided to really create this new brand Launch and Scale is because I absolutely love products that are different and unique and serve a specific purpose in the market. And I've noticed that Kickstarter is an amazing platform to give your brand momentum. So, it's been a great way to literally kickstart a couple of seven-figure brands that I've worked with and multiple other people. And so I thought my sweet spot is not only in product launches but is really helping with that early stage development of fast scale, fast growth, from zero to $5 million points of strong foundations and building an amazing product off of customer feedback, really that is what I've been doing in the field. And so I felt that in keeping the Crowdfunding Uncut podcast to be specific to Kickstarter but now we're really talking about launching and scaling profitable, eCommerce physical brands with predictably and success. So really excited. As mentioned before, episodes are crafted off of your feedback so if you have a question, a topic or you just want to say hi, the best thing to do is to send our team an email at support@khierstyn.com. So again, it's K-H-I-E-R-S-T-Y-N.com. And if you actually schedule a call with me to talk about your product, please head over to khierstyn.com/schedule. Apart from that, I am going to wrap up this intro episode and jump into the first official episode where we are handling the debate between brands or me too products.

If you think nonprofit branding is important, this podcast is for you. We speak with author, speaker, marketer, brand and customer experience evangelist, educator, and consultant Elaine Fogel, president and CMO of Solutions Marketing & Consulting LLC located in Scottsdale, Arizona. A sought-after marketing and branding thought leader who specializes in small-to-medium businesses and nonprofit organizations, Elaine speaks to us about the elements of a strong brand: Purpose Consistency Professionalism Commitment Elaine's background in working with celebrity spokespeople and corporate partnerships with the likes of Nike, Ford, Aventis, and Air Canada has also given her the expertise to write Beyond Your Logo: 7 Brand Ideas That Matter Most for Small Business Success (a 2016 Finalist in the National Indie Excellence Awards as well as the Next Generation Indie Book Awards). We talk about those 7 ideas and more. We also love her blog, Totally Uncorked.

Belén Garijo, Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO Healthcare, on Tuesday February 9. Dr. Garijo’s session was entitled “From Physician to CEO: Leadership Insight for Success.” Belén Garijo is a Member of the Executive Board of Merck KGaA, Darmstadt, Germany, since January 2015. She is responsible for the Healthcare business sector, comprising the businesses of Biopharma, Consumer Health, Allergopharma and Biosimilars. Since 2013 she also acts as President and CEO of Biopharma, where she started in 2011 as Chief Operating Officer. Before joining Merck KGaA, Darmstadt, Germany, Belén Garijo was employed by Sanofi-Aventis as Senior Vice President Global Operations Europe, serving as a member of the Management Committee of the Sanofi-Aventis Group and of the Management Board of the Sanofi-Pasteur vaccines joint venture with MSD. In 2011, she took on the additional role of Global Integration Leader for the Genzyme acquisition. From 2003 to 2006, Belén Garijo was General Manager of Aventis Spain, subsequently leading the merger of Sanofi-Aventis in 2004. From 2000 to 2003 she served as Global Vice President Oncology at Aventis and from 1996 as Director of the Oncology Business Unit in the predecessor company Rhône-Poulenc Rorer. Prior to this she worked in R&D for eight years, initially as the Medical Director of the Abbott Laboratories Spanish affiliate, before moving to lead International Medical Affairs at the Abbott headquarters in Illinois, USA. Belén Garijo is a medical doctor, specialized in clinical pharmacology. She worked as a practicing physician for six years, before moving to the pharmaceutical industry. Belén Garijo is married and has two daughters.

Nick Lane is a biochemist in the Department of Genetics, Evolution and Environment at University College London and leads the UCL Origins of Life Programme. His first book, Oxygen, was one of the Sunday Times Books of the Year in 2002. Power, Sex, Suicide was named as a book of the year in The Economist in 2005 and was short-listed for The Aventis […] See acast.com/privacy for privacy and opt-out information.

1) Orexin receptor antagonism and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Drs. Tom Roth and Joe Herring about their paper on orexin receptor antagonism for treatment of insomnia.Dr. Chafic Karam is reading our e-Pearl of the week about central fourth nerve palsies. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about drugs that can cause encephalopathy. All participants have disclosures.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Roth serves on the scientific advisory boards for Merck, Jazz and Transcept; serves as an editorial board member for Sleep and Sleep Medicine; receives research support from Transcept Pharmaceuticals, Impax Pharmaceuticals, Linguflex LLC and APnes, serves on the speakers' bureau of Purdue Pharma L.P. and is a consultant for Abbott Laboratories, Accadia, Acogolix Inc., Acorda, Actelion Pharmaceuticals Ltd, Addrenex Pharmaceuticals, Inc, Alchemers, Alza Corporation, Ancel, Arena, AstraZeneca, Aventis, AVER, Bayer Schering Pharma, BMS, BTG, Cephalon, Inc., Cypress, Dove, Eisai Inc., Elan Corporation, Eli Lilly and Company, Evotec, Forest Laboratories, Inc., GlaxoSmithKline, Hypnion Inc, Impax Pharmaceuticals, Intec, Intra-Cellular Therapies, Jazz, Johnson & Johnson, King Pharmaceuticals, Lundbeck, Inc., McNeil, MediciNova, Merck, Neurim Pharmaceuticals Ltd, Neurocrine, Neurogen, Novartis, Orexo, Organon Pharmaceuticals, Otsuka Pharmaceuticals, Inc., Prestwick, Proctor & Gamble Pharmaceuticals, Pfizer Inc, Purdue Pharma L.P., Resteva, Roche, Sanofi-aventis, Schoering-Plough Corp., Sepracor Inc., Servier Laboratories, Shire plc, Somaxon Pharmaceuticals, Syrex, Takeda Pharmaceutical Company Limited, TransOral, Yanda, VivoMetrics Inc, Wyeth, Yamanuchi Pharmaceutical, and XenoPort.Dr. Herring is Executive Director, Clinical Neuroscience at Merck; receives research support as an employee at Merck and holds stock options with Merck.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.